Using Wearable Technology to Detect Symptoms of Posttraumatic Stress Disorder

NCT ID: NCT05534100

Last Updated: 2023-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and report their symptoms over the past weeks or months. Such assessment procedures are negatively impacted by individuals' abilities to accurately recall information. Moreover, retrospective assessments provide little information about how symptoms are experienced in the moment and how these experiences then lead to other behaviors. The proposed project addresses these limitations by assessing PTSD symptoms and associated biological markers (e.g., sleep, heart rate, heart rate variability) in real-time by asking subjects to wear a smart device and complete brief surveys. Data will be collected from 50 individuals with PTSD and 20 healthy controls to help us better understand individuals' real-time experience with PTSD and lay the foundation to develop algorithms for possible in-the-moment interventions in the future.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Control

Biostrap EVO Wristband

Intervention Type DEVICE

Participants in both groups will wear the Biostrap wearable device

PTSD

Biostrap EVO Wristband

Intervention Type DEVICE

Participants in both groups will wear the Biostrap wearable device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biostrap EVO Wristband

Participants in both groups will wear the Biostrap wearable device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Are 18 years or older
2. Are fluent in English
3. Have an active smart phone or smart device with full data and Bluetooth capability
4. Have experienced a Criterion A traumatic event during their lifetime
5. Have a PTSD diagnosis verified by the Clinician Administered PTSD Scale for DSM-5 and a symptom severity score of 35 or higher.
6. Are willing and able to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
7. Are willing to wear a smart device 24/7 over the course of one month.


Individuals are eligible for the current study if they:

1. Are 18 years or older
2. Are fluent in English
3. Have an active smart phone or smart device with full data and Bluetooth capability
4. Are willing and able to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
5. Are willing to wear a smart device 24/7 over the course of one month.

Exclusion Criteria

1. The traumatic event occurred in the past month
2. They are currently suicidal or homicidal
3. They have a history of psychosis or mania
4. They have a known, diagnosed heart condition
5. They are currently receiving treatment for their PTSD or have completed an evidence- based PTSD treatment in the past 3 months
6. They have a serious or unstable medical illness or instability for which hospitalization may be likely
7. Subjects who, at the time of consent, appear to have extenuating life circumstances (unstable housing, no internet access, etc.) which, in the judgement of the Principal Investigator, could affect their ability to participate in the study


Individuals are excluded from the current study if they:

1. Score a 10 or higher on the Clinician Administered PTSD Scale for DSM-5
2. Known or diagnosed heart condition
3. Known or diagnosed psychiatric condition
4. Currently or have previously received psychiatric care in the past 3 months
5. Subjects who, at the time of consent, appear to have extenuating life circumstances (unstable housing, no internet access, etc.) which, in the judgement of the Principal Investigator, could affect their ability to participate in the trial
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rush University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Philip Held

Research Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21090706

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cognitive Training for PTSD
NCT03316196 COMPLETED NA